IMA Clinical Research

IMA Clinical Research is a flexible clinical trial network dedicated to advancing the development of new medical treatments through compassionate and patient-centric approaches. With a nationwide presence, the organization offers site-based, hybrid, and fully decentralized clinical trials, ensuring broad access to diverse patient populations. With over 15 full-service clinical trial sites and 180 satellite locations, IMA Clinical Research boasts a robust patient database of 400,000 unique weekly visits. The network is committed to providing high-quality data to sponsors and CROs, facilitating the enrollment of qualified participants and accelerating the development of novel treatments. Generated from the website

IMA Clinical Research is a flexible clinical trial network dedicated to advancing the development of new medical treatments through a compassionate approach to clinical research services. With a robust infrastructure that includes 15 full-service clinical trial sites and 180 satellite locations across the United States, IMA aims to enhance patient access to innovative treatments. The organization prides itself on its ability to enroll diverse participants and provide high-quality data to sponsors and CROs, facilitating the acceleration of novel treatment development. By leveraging patient-centric technology, IMA supports a flexible trial model that can adapt to the needs of patients and sponsors alike. Generated from the website

IMA Clinical Research is a flexible clinical trial network dedicated to advancing the development of new medical treatments through a compassionate approach to clinical research services. With a robust infrastructure that includes 15 full-service clinical trial sites and 180 satellite locations nationwide, the organization emphasizes patient-centric technology and broad diversity in participant recruitment. Committed to providing sponsors and CROs with high-quality data, IMA Clinical Research excels in enrolling qualified participants and navigating complex situations to accelerate the development of novel treatments. Their innovative trial models facilitate access to new therapies, ensuring that patients everywhere can benefit from cutting-edge medical advancements. Generated from the website